VILLA, Erica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.305
AS - Asia 13.431
EU - Europa 11.858
SA - Sud America 2.222
AF - Africa 349
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 24
Totale 60.224
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.885
SG - Singapore 4.394
GB - Regno Unito 3.689
CN - Cina 3.515
BR - Brasile 1.731
HK - Hong Kong 1.573
IT - Italia 1.567
VN - Vietnam 1.510
SE - Svezia 1.275
DE - Germania 1.244
FI - Finlandia 899
PL - Polonia 716
RU - Federazione Russa 598
TR - Turchia 561
UA - Ucraina 548
FR - Francia 481
KR - Corea 425
IN - India 292
BG - Bulgaria 268
ID - Indonesia 215
AR - Argentina 174
CA - Canada 173
BD - Bangladesh 163
MX - Messico 129
NL - Olanda 115
JP - Giappone 102
ZA - Sudafrica 102
IQ - Iraq 97
AE - Emirati Arabi Uniti 78
EC - Ecuador 68
PK - Pakistan 68
ES - Italia 64
BE - Belgio 58
CO - Colombia 56
MA - Marocco 54
LT - Lituania 53
EG - Egitto 52
IE - Irlanda 52
AT - Austria 50
VE - Venezuela 50
CL - Cile 46
MY - Malesia 44
UZ - Uzbekistan 44
KE - Kenya 40
PH - Filippine 40
SA - Arabia Saudita 36
NP - Nepal 35
JO - Giordania 34
PE - Perù 31
PY - Paraguay 30
BZ - Belize 26
AU - Australia 25
CZ - Repubblica Ceca 25
DZ - Algeria 25
TN - Tunisia 23
RO - Romania 20
IL - Israele 19
UY - Uruguay 19
AZ - Azerbaigian 18
TH - Thailandia 18
CH - Svizzera 17
IR - Iran 17
CR - Costa Rica 16
EU - Europa 16
AL - Albania 15
BO - Bolivia 15
DO - Repubblica Dominicana 15
LB - Libano 15
KZ - Kazakistan 14
RS - Serbia 14
GE - Georgia 13
QA - Qatar 13
HU - Ungheria 12
OM - Oman 12
BH - Bahrain 11
DK - Danimarca 11
ET - Etiopia 11
HN - Honduras 11
JM - Giamaica 10
LV - Lettonia 10
PA - Panama 10
SK - Slovacchia (Repubblica Slovacca) 10
NZ - Nuova Zelanda 9
SI - Slovenia 9
TW - Taiwan 9
BY - Bielorussia 8
SN - Senegal 8
AO - Angola 7
GT - Guatemala 6
KG - Kirghizistan 6
TT - Trinidad e Tobago 6
AM - Armenia 5
GR - Grecia 5
LA - Repubblica Popolare Democratica del Laos 5
PT - Portogallo 5
CY - Cipro 4
GA - Gabon 4
MN - Mongolia 4
NO - Norvegia 4
PR - Porto Rico 4
Totale 60.138
Salva come PNG Salva come JPEG
Città #
Fairfield 3.544
Ashburn 3.041
Santa Clara 2.808
Singapore 2.713
Southend 2.383
Woodbridge 1.967
Houston 1.902
Chandler 1.660
Hong Kong 1.524
Seattle 1.350
Wilmington 1.213
Cambridge 1.121
Ann Arbor 1.067
Jacksonville 1.018
Hefei 981
New York 808
Dearborn 789
San Jose 758
Nyköping 741
Helsinki 734
London 711
Warsaw 688
Beijing 606
Los Angeles 537
Chicago 528
Modena 500
Ho Chi Minh City 481
The Dalles 400
Izmir 377
Hanoi 364
Seoul 338
San Diego 316
Princeton 267
Sofia 259
Council Bluffs 256
Grafing 255
Lauterbourg 234
Shanghai 197
Salt Lake City 195
Eugene 183
Buffalo 178
Moscow 171
São Paulo 167
Jakarta 156
Jersey City 154
Munich 135
Redwood City 130
Dallas 115
Des Moines 113
Tampa 96
Orem 94
Frankfurt am Main 89
Bremen 87
Columbus 87
Tokyo 84
Elk Grove Village 82
Milan 78
Rio de Janeiro 65
Bologna 61
Da Nang 60
Redondo Beach 60
Atlanta 59
Bupyeong-gu 59
Brooklyn 58
Guangzhou 58
Boardman 54
Brussels 54
Phoenix 54
Haiphong 53
Chennai 52
Johannesburg 51
San Mateo 48
Dublin 47
Falls Church 47
Montreal 47
Norwalk 47
Belo Horizonte 43
Denver 42
Kent 42
Nanjing 42
Rome 42
Nuremberg 41
Tashkent 41
Baghdad 40
Sterling 38
Mexico City 37
Philadelphia 36
Nairobi 33
Fremont 32
Toronto 32
Brasília 31
Dhaka 31
Paris 31
Stockholm 30
Amman 29
Biên Hòa 29
Poplar 29
Turku 29
Vancouver 29
Amsterdam 28
Totale 43.701
Salva come PNG Salva come JPEG
Nome #
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease 698
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 614
AISF position paper on liver disease and pregnancy 576
Non-alcoholic steatohepatitis and liver transplantation 518
Intestinal/multivisceral transplantation: University of Modena experience 448
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 439
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 427
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study 422
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis 416
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 403
Orthogonal polarization spectral imaging: A new tool in morphologic surveillance in intestinal transplant recipients 389
Outcomes after adult isolated small bowel transplantation: experience from a single European centre. 386
ANTICOAGULANT THERAPY IS SAFE AND EFFECTIVE IN PREVENTING PORTAL VEIN THROMBOSIS (PVT) IN ADVANCED CIRRHOTIC PATIENTS: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 386
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 381
Coagulopathy in liver diseases: complication or therapy? 377
Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times 376
Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C 373
Cardiopulmonary hemodynamics and c-reactive protein as prognostic indicators in compensated and decompensated cirrhosis 368
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 360
PROGRESSIVE ALTERATIONS IN SYSTEMIC AND CARDIOPULMONARY HEMODYNAMICS OCCUR IN PATIENTS WITH CIRRHOSIS AND PREDICT DEATH IN DECOMPENSATED CIRRHOSIS 356
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 347
Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool 346
Alcohol and Hepatitis B Virus Infection 341
Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial 331
Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. 330
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 330
Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. 329
Fulminant onset of spontaneous bacterial peritonitis. 323
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 319
Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: sequence analysis and therapeutic strategy 312
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 311
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 310
Variant estrogen receptors and their role in liver disease 309
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 309
Hepatic allograft salvage with early Doppler ultrasound diagnosis of acute vena cava thrombosis 307
High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: Long term results of a prospective randomized trial 297
De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients 296
Efficacy of a Novel Granulocyte Monocyte Apheresis Adsorber Device in the Treatment of Inflammatory Bowel Diseases: A Pilot Study 295
Low molecular weight heparin does not increase bleeding and mortality post endoscopic variceal band ligation in cirrhotic patients 295
ENOXAPARIN PREVENTS PORTAL VEIN THROMBOSIS (PVT) AND DECOMPENSATION IN ADVANCED CIRRHOTIC PATIENTS: FINAL REPORT OF A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 294
Statements from the Taormina expert meeting on occult hepatitis B virus infection. 293
Estrogen receptor alpha mRNA variant lacking exon 5 is co-expressed with the wild-type in endometrial adenocarcinoma 290
Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women 288
Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol. 287
Reproductive status is associated with the severity of fibrosis in women with hepatitis C. 287
Pretransplantation pre-S2 and S protein heterogeneity predisposes to hepatitis B virus recurrence after liver transplantation 287
Complete resolution of non-necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection 286
Missed treatment in an Italian HBV infected patients cohort: HBV RER 286
Estrogen receptor classification for hepatocellular carcinoma: Comparison with clinical staging systems 285
Clinical staging systems for hepatocellular carcinoma: Comparison with estrogen receptor classification 284
Selection of more pathogenic hepatitis C virus genotype II during long-term follow-up of interferon-treated patients. 282
Methylprednisolone-induced toxic hepatitis after intravenous pulsed therapy for multiple sclerosis relapses 282
HEPATITIS-C VIRUS TESTING IN PRIMARY BILIARY-CIRRHOSIS 281
Ethanol-induced increase in cytosolic estrogen receptors in human male liver: a possible explanation for biochemical feminization in chronic liver disease due to alcohol. 280
Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis 280
Obese zebrafish: A small fish for a major human health condition 280
Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis 279
Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis. 277
From current status to optimization of HCV treatment: Recommendations from an expert panel 272
HEPATITIS-B VIRUS SPECIFIC TRANSCRIPTS IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS 270
A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon 270
Influence of age and gender before and after liver transplantation 267
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 267
Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma 266
Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus - A prospective, double-blind, randomized study 264
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals 264
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 264
Hepatocellular carcinoma - Role of estrogen receptors in the liver 263
Massive GI bleeding due to accidental ASA inhalation. 263
Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant 263
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study 262
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 262
Flow-dependent shear stress affects the biological properties of pericyte-like cells isolated from human dental pulp 260
Sex hormones and liver cancer 257
Translating pharmacogenetics into clinical practice: interleukin (IL)28B and inosine triphosphatase (ITPA) polymophisms in hepatitis C virus (HCV) infection. 257
EVIDENCE FOR HEPATITIS-B VIRUS-INFECTION IN PATIENTS WITH CHRONIC HEPATITIS-C WITH AND WITHOUT SEROLOGICAL MARKERS OF HEPATITIS-B 257
Interleukin 28B genotype determination using DNA from different sources: A simple and reliable tool for the epidemiological and clinical characterization of hepatitis C. 257
Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients? 256
Treatment of nonalcoholic steatohepatitis in adults: present and future 255
Estrogens receptors and oxidative damage in the liver 255
Beneficial hemodynamic effects of dipyridamole on portal circulation in cirrhosis 254
LOW MOLECULAR WEIGHT HEPARIN TREATMENT DOES NOT INCREASE THE RISK OF BLEEDING AFTER PROPHYLACTIC ENDOSCOPIC VARICEAL BAND LIGATION IN PATIENTS WITH CIRRHOSIS 254
Gastrointestinal endoscopy and HBV infection: no evidence for a causal relationship. A prospective controlled study. 252
"Blindly" ADA Dose Escalation to 80 mg Weekly in Crohn's Disease Patients with LOR: Is It Cost Effective or Not? 252
No inflammation? No cancer! Clear HBV early and live happily. 251
BactDNA as an Independent Risk Factor for Short-Term Crohn's Disease Recurrence 251
Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study 249
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis 249
Successful liver transplantation in a patient with splanchnic vein thrombosis and pulmonary embolism due to polycythemia vera with Jak2v617f mutation and heparin-induced thrombocytopenia. 248
HCV RNA IN SERUM OF ASYMPTOMATIC BLOOD-DONORS INVOLVED IN POSTTRANSFUSION HEPATITIS (PTH) 247
Experimental hepatology applied to stem cells 246
Hepatitis B virus infection of peripheral blood mononuclear cells is common in acute and chronic hepatitis. 246
Androgen receptor alterations in hepatocarcinogenesis. 245
PRESENCE OF HCV RNA IN SERUM OF ASYMPTOMATIC BLOOD-DONORS INVOLVED IN POSTTRANSFUSION HEPATITIS (PTH) 243
Anticoagulation in cirrhosis: a new paradigm? 241
Natural history of inoperable hepatocellular carcinoma: Estrogen receptors' status in the tumor is the strongest prognostic factor for survival 238
The prevalence of asymptomatic early sacroiliitis in Crohn’s disease patients: The single experience of an Italian tertiary care centre 238
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program 237
Current and future challenges in HCV: insights from an Italian experts panel 236
Impact of a Multidisciplinary Team on Alcohol Recidivism and Survival After Liver Transplant for Alcoholic Disease 236
Totale 30.842
Salva come PNG Salva come JPEG
Categoria #
all - tutte 239.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 239.441
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.550 0 0 0 0 0 0 0 0 0 691 552 307
2021/20224.917 334 550 347 283 133 262 508 267 502 407 847 477
2022/20234.592 561 524 353 437 503 713 62 423 537 45 205 229
2023/20242.643 118 177 211 281 460 221 241 328 67 54 158 327
2024/202510.333 339 101 140 736 2.059 1.529 613 679 1.472 659 869 1.137
2025/202618.183 1.256 725 1.591 2.359 2.989 2.668 2.286 1.066 1.843 1.400 0 0
Totale 60.653